Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Roberts

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Mutation Research|March 22, 2000
Species differences in peroxisome proliferation; mechanisms and relevanceA I Choudhury, S Chahal, A R Bell, et al.
Archives of Toxicology|January 5, 2002
Scientific analysis of the proposed uses of the T25 dose descriptor in chemical carcinogen regulationR A Roberts, K S Crump, W K Lutz, et al.
Biochemical Pharmacology|April 1, 1987
Proteoglycan degradation by a chondrocyte metalloprotease. Effects of synthetic protease inhibitorsC B Caputo, D J Wolanin, R A Roberts, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1987
Effect of synthetic metalloprotease inhibitors on cartilage autolysis in vitroC B Caputo, L A Sygowski, D J Wolanin, et al.
Toxicologic Pathology|August 24, 2011
Induction of heart valve lesions by small-molecule ALK5 inhibitorsMark J Anderton, Howard R Mellor, Alex Bell, et al.
Toxicology Letters|March 18, 2000
Apoptosis and proliferation in nongenotoxic carcinogenesis: species differences and role of PPARalphaR A Roberts, N H James, S C Hasmall, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|March 22, 2000
Tumour necrosis factor alpha (TNFalpha): role in suppression of apoptosis by the peroxisome proliferator nafenopinP R Holden, S C Hasmall, N H James, et al.
Pharmaceutical Development and Technology|February 23, 1999
Application of near-infrared spectroscopy for nondestructive analysis of Avicel powders and tabletsN K Ebube, S S Thosar, R A Roberts, et al.
The EMBO Journal|August 3, 2001
The p41 isoform of invariant chain is a chaperone for cathepsin LA M Lennon-Duménil, R A Roberts, K Valentijn, et al.
Toxicology Letters|February 18, 1999
Peroxisome proliferator-activated receptor (PPAR) alpha-regulated growth responses and their importance to hepatocarcinogenesisN H James, J H Gill, R Brindle, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Mutation Research|March 22, 2000
Species differences in peroxisome proliferation; mechanisms and relevanceA I Choudhury, S Chahal, A R Bell, et al.
Archives of Toxicology|January 5, 2002
Scientific analysis of the proposed uses of the T25 dose descriptor in chemical carcinogen regulationR A Roberts, K S Crump, W K Lutz, et al.
Biochemical Pharmacology|April 1, 1987
Proteoglycan degradation by a chondrocyte metalloprotease. Effects of synthetic protease inhibitorsC B Caputo, D J Wolanin, R A Roberts, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1987
Effect of synthetic metalloprotease inhibitors on cartilage autolysis in vitroC B Caputo, L A Sygowski, D J Wolanin, et al.
Toxicologic Pathology|August 24, 2011
Induction of heart valve lesions by small-molecule ALK5 inhibitorsMark J Anderton, Howard R Mellor, Alex Bell, et al.
Toxicology Letters|March 18, 2000
Apoptosis and proliferation in nongenotoxic carcinogenesis: species differences and role of PPARalphaR A Roberts, N H James, S C Hasmall, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|March 22, 2000
Tumour necrosis factor alpha (TNFalpha): role in suppression of apoptosis by the peroxisome proliferator nafenopinP R Holden, S C Hasmall, N H James, et al.
Pharmaceutical Development and Technology|February 23, 1999
Application of near-infrared spectroscopy for nondestructive analysis of Avicel powders and tabletsN K Ebube, S S Thosar, R A Roberts, et al.
The EMBO Journal|August 3, 2001
The p41 isoform of invariant chain is a chaperone for cathepsin LA M Lennon-Duménil, R A Roberts, K Valentijn, et al.
Toxicology Letters|February 18, 1999
Peroxisome proliferator-activated receptor (PPAR) alpha-regulated growth responses and their importance to hepatocarcinogenesisN H James, J H Gill, R Brindle, et al.
Pageof 11